
France-Israel: 4P-Pharma, SATT Aquitaine and Bordeaux University to develop an anti-cancer drug. Video
4P-Pharma has signed an exclusive license agreement with Aquitaine Science Transfert, for…

4P-Pharma has signed an exclusive license agreement with Aquitaine Science Transfert, for…
Rapid Medical, a company focused on the development of neurovascular interventional devices,…

In a landmark discovery, researchers at Tel Aviv University have unraveled the…

Age-associated motor and cognitive deficits increase the risk of falls, a major…

The ejection of internal organs, i.e., evisceration, is a well-known phenomenon in…